Silvercrest Asset Management’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.2M | Sell |
301,376
-43,370
| -13% | -$4.45M | 0.21% | 133 |
|
|
2025
Q4 | $36.6M | Sell |
344,746
-16,451
| -5% | -$1.91M | 0.25% | 111 |
|
|
2025
Q3 | $45.9M | Buy |
361,197
+30,497
| +9% | +$3.63M | 0.3% | 97 |
|
|
2025
Q2 | $40.6M | Sell |
330,700
-14,049
| -4% | -$1.6M | 0.27% | 108 |
|
|
2025
Q1 | $34.9M | Buy |
344,749
+4,658
| +1% | +$455K | 0.25% | 117 |
|
|
2024
Q4 | $31.4M | Buy |
340,091
+181,693
| +115% | +$17.8M | 0.21% | 135 |
|
|
2024
Q3 | $15.3M | Sell |
158,398
-1,214
| -0.8% | -$109K | 0.1% | 211 |
|
|
2024
Q2 | $13.7M | Sell |
159,612
-92,378
| -37% | -$7.75M | 0.09% | 218 |
|
|
2024
Q1 | $20.8M | Buy |
251,990
+4,258
| +2% | +$312K | 0.14% | 176 |
|
|
2023
Q4 | $16.5M | Sell |
247,732
-10,724
| -4% | -$695K | 0.12% | 187 |
|
|
2023
Q3 | $17.4M | Sell |
258,456
-13,416
| -5% | -$923K | 0.13% | 178 |
|
|
2023
Q2 | $18.4M | Buy |
271,872
+25,851
| +11% | +$1.62M | 0.13% | 182 |
|
|
2023
Q1 | $13.3M | Sell |
246,021
-5,009
| -2% | -$292K | 0.1% | 197 |
|
|
2022
Q4 | $15M | Sell |
251,030
-6,143
| -2% | -$334K | 0.12% | 182 |
|
|
2022
Q3 | $11.6M | Sell |
257,173
-65,347
| -20% | -$3.27M | 0.1% | 205 |
|
|
2022
Q2 | $14.4M | Buy |
322,520
+2,601
| +0.8% | +$133K | 0.11% | 196 |
|
|
2022
Q1 | $18.1M | Buy |
319,919
+145,097
| +83% | +$7.58M | 0.12% | 191 |
|
|
2021
Q4 | $9.02M | Buy |
174,822
+1,807
| +1% | +$93.2K | 0.06% | 276 |
|
|
2021
Q3 | $10.3M | Sell |
173,015
-7,864
| -4% | -$495K | 0.07% | 259 |
|
|
2021
Q2 | $11.2M | Sell |
180,879
-2,687
| -1% | -$179K | 0.07% | 254 |
|
|
2021
Q1 | $12M | Buy |
183,566
+3,047
| +2% | +$199K | 0.08% | 243 |
|
|
2020
Q4 | $11.9M | Buy |
180,519
+3,927
| +2% | +$231K | 0.09% | 225 |
|
|
2020
Q3 | $9.13M | Buy |
176,592
+5,098
| +3% | +$262K | 0.08% | 237 |
|
|
2020
Q2 | $8.45M | Buy |
171,494
+13,712
| +9% | +$740K | 0.07% | 236 |
|
|
2020
Q1 | $8.04M | Sell |
157,782
-752
| -0.5% | -$43.4K | 0.09% | 216 |
|
|
2019
Q4 | $8.74M | Buy |
158,534
+4,247
| +3% | +$230K | 0.07% | 246 |
|
|
2019
Q3 | $7.77M | Sell |
154,287
-28,089
| -15% | -$1.41M | 0.06% | 245 |
|
|
2019
Q2 | $9.19M | Buy |
182,376
+25,099
| +16% | +$1.22M | 0.09% | 182 |
|
|
2019
Q1 | $7.31M | Buy |
157,277
+16,079
| +11% | +$815K | 0.07% | 192 |
|
|
2018
Q4 | $6.93M | Buy |
141,198
+7,610
| +6% | +$433K | 0.08% | 195 |
|
|
2018
Q3 | $8.28M | Buy |
133,588
+24,166
| +22% | +$1.47M | 0.08% | 193 |
|
|
2018
Q2 | $5.89M | Buy |
109,422
+4,358
| +4% | +$218K | 0.06% | 225 |
|
|
2018
Q1 | $4.78M | Buy |
+105,064
| New | +$4.5M | 0.05% | 236 |
|
Other funds holding EHC
VPM
VCM
Silvercrest Asset Management's EHC Position: Q1 2026 in Review
Silvercrest Asset Management reduced its Encompass Health (EHC) stake by 13% in Q1 2026, selling an estimated $4.45M and leaving 301,376 shares worth $29.2M. The position accounts for 0.21% of the portfolio, ranked #133.
Silvercrest Asset Management first reported a position in EHC in Q1 2018 and has held it in 33 quarters since. The position peaked at $45.9M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Silvercrest Asset Management held 301,376 shares of Encompass Health worth $29.2M as of Q1 2026.
- Silvercrest Asset Management sold 43,370 Encompass Health shares in Q1 2026, an estimated $4.45M.
- Encompass Health made up 0.21% of Silvercrest Asset Management's portfolio in Q1 2026, its #133 holding.
- Silvercrest Asset Management first reported a position in Encompass Health in Q1 2018 and has held it in 33 quarters since.
- Silvercrest Asset Management's Encompass Health position peaked at $45.9M in Q3 2025.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.